FiberNet Embolic Protection System (EPS) (Lumen Biomedical Inc.) for carotid artery stenting
Record ID 32012000141
English
Authors' recommendations:
Partial blockage of the carotid arteries (stenosis) due to atherosclerosis is a risk factor for stroke, which affects approximately 795,000 people in the United States each year. For patients with carotid artery stenosis who are at increased risk for stroke, carotid endarterectomy is the standard surgery for removing the plaque and reducing the risk of ischemia. A minimally invasive alternative to open surgery is percutaneous transluminal carotid angioplasty and stenting. In this procedure, catheters are inserted through the vessels to open arterial blockages and to deliver stents that help keep arteries open; however, the atherosclerotic material causing the blockage can break up while it is being manipulated by the catheters, generating fragments that can travel to and damage the brain and other organs. Newer technologies have been developed to reduce the risk of embolism during carotid artery stenting, known as protected carotid artery stenting, and to improve the outcomes of this therapy.
Details
Project Status:
Completed
Year Published:
2011
URL for published report:
http://www.hayesinc.com/hayes/crd/?crd=10168
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Angioplasty, Balloon
- Stents
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2011 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.